Thomaspartners’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q1 | $276M | Buy |
8,196,496
+240,149
| +3% | +$8.09M | 2.02% | 20 |
|
|
2017
Q4 | $273M | Buy |
7,956,347
+223,817
| +3% | +$7.69M | 2% | 18 |
|
|
2017
Q3 | $262M | Buy |
7,732,530
+241,556
| +3% | +$8.18M | 2.1% | 18 |
|
|
2017
Q2 | $239M | Buy |
7,490,974
+494,547
| +7% | +$15.8M | 2.05% | 21 |
|
|
2017
Q1 | $227M | Buy |
6,996,427
+701,293
| +11% | +$22.8M | 2.09% | 19 |
|
|
2016
Q4 | $194M | Buy |
6,295,134
+560,038
| +10% | +$17.3M | 2.1% | 20 |
|
|
2016
Q3 | $184M | Buy |
5,735,096
+361,042
| +7% | +$11.6M | 2.25% | 15 |
|
|
2016
Q2 | $180M | Buy |
5,374,054
+299,489
| +6% | +$10M | 2.35% | 15 |
|
|
2016
Q1 | $143M | Buy |
5,074,565
+213,454
| +4% | +$6M | 2.05% | 19 |
|
|
2015
Q4 | $149M | Buy |
4,861,111
+144,205
| +3% | +$4.42M | 2.29% | 7 |
|
|
2015
Q3 | $141M | Buy |
4,716,906
+45,082
| +1% | +$1.34M | 2.37% | 6 |
|
|
2015
Q2 | $149M | Buy |
4,671,824
+66,558
| +1% | +$2.12M | 2.4% | 2 |
|
|
2015
Q1 | $152M | Buy |
4,605,266
+298,143
| +7% | +$9.84M | 2.47% | 1 |
|
|
2014
Q4 | $127M | Buy |
4,307,123
+361,844
| +9% | +$10.7M | 2.19% | 8 |
|
|
2014
Q3 | $111M | Buy |
3,945,279
+315,487
| +9% | +$8.85M | 2.16% | 11 |
|
|
2014
Q2 | $102M | Buy |
3,629,792
+634,775
| +21% | +$17.9M | 2.13% | 10 |
|
|
2014
Q1 | $91.3M | Buy |
2,995,017
+855,317
| +40% | +$26.1M | 2.19% | 3 |
|
|
2013
Q4 | $62.2M | Buy |
2,139,700
+424,697
| +25% | +$12.3M | 1.71% | 32 |
|
|
2013
Q3 | $46.7M | Buy |
1,715,003
+359,004
| +26% | +$9.78M | 1.68% | 26 |
|
|
2013
Q2 | $40.1M | Buy |
+1,355,999
| New | +$40.1M | 1.57% | 29 |
|